Global and China Pharmacovigilance (PV) Outsourcing Market Size, Status and Forecast 2021-2027

SKU ID :QYR-19076043 | Published Date: 03-Sep-2021 | No. of pages: 129
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Contract Research Organizations (CROs) 1.2.3 Business Process Outsourcing (BPOs) 1.3 Market by Application 1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Premarketing Clinical Trial 1.3.3 Post-marketing Clinical Practice 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2016-2027) 2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Regions 2.2.1 Pharmacovigilance (PV) Outsourcing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Share by Regions (2016-2021) 2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Regions (2022-2027) 2.3 Pharmacovigilance (PV) Outsourcing Industry Dynamic 2.3.1 Pharmacovigilance (PV) Outsourcing Market Trends 2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers 2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges 2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue 3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2016-2021) 3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2016-2021) 3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue 3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio 3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2020 3.5 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served 3.6 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service 3.7 Date of Enter into Pharmacovigilance (PV) Outsourcing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type 4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2016-2021) 4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2022-2027) 5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application 5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2016-2021) 5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2016-2027) 6.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type 6.2.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 6.2.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) 6.2.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2027) 6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Application 6.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 6.3.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) 6.3.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2027) 6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country 6.4.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) 6.4.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2016-2027) 7.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type 7.2.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 7.2.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) 7.2.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2027) 7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application 7.3.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 7.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) 7.3.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2027) 7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country 7.4.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) 7.4.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2016-2027) 8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type 8.2.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2027) 8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application 8.3.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2027) 8.4 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region 8.4.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2016-2027) 9.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type 9.2.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 9.2.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) 9.2.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2027) 9.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application 9.3.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 9.3.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) 9.3.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2027) 9.4 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country 9.4.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) 9.4.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2016-2027) 10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type 10.2.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2027) 10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application 10.3.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2027) 10.4 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country 10.4.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Accenture 11.1.1 Accenture Company Details 11.1.2 Accenture Business Overview 11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction 11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.1.5 Accenture Recent Development 11.2 C3i Solutions 11.2.1 C3i Solutions Company Details 11.2.2 C3i Solutions Business Overview 11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction 11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.2.5 C3i Solutions Recent Development 11.3 Clintec 11.3.1 Clintec Company Details 11.3.2 Clintec Business Overview 11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction 11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.3.5 Clintec Recent Development 11.4 Covance 11.4.1 Covance Company Details 11.4.2 Covance Business Overview 11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction 11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.4.5 Covance Recent Development 11.5 Deloitte Touche Tohmatsu Limited 11.5.1 Deloitte Touche Tohmatsu Limited Company Details 11.5.2 Deloitte Touche Tohmatsu Limited Business Overview 11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction 11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.5.5 Deloitte Touche Tohmatsu Limited Recent Development 11.6 ELC Group 11.6.1 ELC Group Company Details 11.6.2 ELC Group Business Overview 11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction 11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.6.5 ELC Group Recent Development 11.7 Ergomed 11.7.1 Ergomed Company Details 11.7.2 Ergomed Business Overview 11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction 11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.7.5 Ergomed Recent Development 11.8 iGATE Corporation 11.8.1 iGATE Corporation Company Details 11.8.2 iGATE Corporation Business Overview 11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction 11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.8.5 iGATE Corporation Recent Development 11.9 iMED Global Corporation 11.9.1 iMED Global Corporation Company Details 11.9.2 iMED Global Corporation Business Overview 11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction 11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.9.5 iMED Global Corporation Recent Development 11.10 IQVIA 11.10.1 IQVIA Company Details 11.10.2 IQVIA Business Overview 11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction 11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.10.5 IQVIA Recent Development 11.11 MarksMan Healthcare 11.11.1 MarksMan Healthcare Company Details 11.11.2 MarksMan Healthcare Business Overview 11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction 11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.11.5 MarksMan Healthcare Recent Development 11.12 Medpace Holdings 11.12.1 Medpace Holdings Company Details 11.12.2 Medpace Holdings Business Overview 11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction 11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.12.5 Medpace Holdings Recent Development 11.13 Novartis 11.13.1 Novartis Company Details 11.13.2 Novartis Business Overview 11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction 11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.13.5 Novartis Recent Development 11.14 Oracle Corporation 11.14.1 Oracle Corporation Company Details 11.14.2 Oracle Corporation Business Overview 11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction 11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.14.5 Oracle Corporation Recent Development 11.15 Parexel 11.15.1 Parexel Company Details 11.15.2 Parexel Business Overview 11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction 11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.15.5 Parexel Recent Development 11.16 PharmInvent 11.16.1 PharmInvent Company Details 11.16.2 PharmInvent Business Overview 11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction 11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.16.5 PharmInvent Recent Development 11.17 PrimeVigilance 11.17.1 PrimeVigilance Company Details 11.17.2 PrimeVigilance Business Overview 11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction 11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.17.5 PrimeVigilance Recent Development 11.18 Pure Drug Safety 11.18.1 Pure Drug Safety Company Details 11.18.2 Pure Drug Safety Business Overview 11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction 11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.18.5 Pure Drug Safety Recent Development 11.18 Sciformix .1 Sciformix Company Details .2 Sciformix Business Overview .3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction .4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) .5 Sciformix Recent Development 11.20 SIRO Clinpharm 11.20.1 SIRO Clinpharm Company Details 11.20.2 SIRO Clinpharm Business Overview 11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction 11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.20.5 SIRO Clinpharm Recent Development 11.21 Symogen 11.21.1 Symogen Company Details 11.21.2 Symogen Business Overview 11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction 11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) 11.21.5 Symogen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Contract Research Organizations (CROs) Table 3. Key Players of Business Process Outsourcing (BPOs) Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Pharmacovigilance (PV) Outsourcing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions (2016-2021) Table 8. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions (2022-2027) Table 10. Pharmacovigilance (PV) Outsourcing Market Trends Table 11. Pharmacovigilance (PV) Outsourcing Market Drivers Table 12. Pharmacovigilance (PV) Outsourcing Market Challenges Table 13. Pharmacovigilance (PV) Outsourcing Market Restraints Table 14. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Pharmacovigilance (PV) Outsourcing Market Share by Players (2016-2021) Table 16. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2020) Table 17. Ranking of Global Top Pharmacovigilance (PV) Outsourcing Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service Table 21. Date of Enter into Pharmacovigilance (PV) Outsourcing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 24. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2016-2021) Table 25. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2016-2021) Table 29. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 32. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 34. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2022-2027) & (US$ Million) Table 61. Accenture Company Details Table 62. Accenture Business Overview Table 63. Accenture Pharmacovigilance (PV) Outsourcing Product Table 64. Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 65. Accenture Recent Development Table 66. C3i Solutions Company Details Table 67. C3i Solutions Business Overview Table 68. C3i Solutions Pharmacovigilance (PV) Outsourcing Product Table 69. C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 70. C3i Solutions Recent Development Table 71. Clintec Company Details Table 72. Clintec Business Overview Table 73. Clintec Pharmacovigilance (PV) Outsourcing Product Table 74. Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 75. Clintec Recent Development Table 76. Covance Company Details Table 77. Covance Business Overview Table 78. Covance Pharmacovigilance (PV) Outsourcing Product Table 79. Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 80. Covance Recent Development Table 81. Deloitte Touche Tohmatsu Limited Company Details Table 82. Deloitte Touche Tohmatsu Limited Business Overview Table 83. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Table 84. Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 85. Deloitte Touche Tohmatsu Limited Recent Development Table 86. ELC Group Company Details Table 87. ELC Group Business Overview Table 88. ELC Group Pharmacovigilance (PV) Outsourcing Product Table 89. ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 90. ELC Group Recent Development Table 91. Ergomed Company Details Table 92. Ergomed Business Overview Table 93. Ergomed Pharmacovigilance (PV) Outsourcing Product Table 94. Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 95. Ergomed Recent Development Table 96. iGATE Corporation Company Details Table 97. iGATE Corporation Business Overview Table 98. iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 99. iGATE Corporation Recent Development Table 100. iMED Global Corporation Company Details Table 101. iMED Global Corporation Business Overview Table 102. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Table 103. iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 104. iMED Global Corporation Recent Development Table 105. IQVIA Company Details Table 106. IQVIA Business Overview Table 107. IQVIA Pharmacovigilance (PV) Outsourcing Product Table 108. IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 109. IQVIA Recent Development Table 110. MarksMan Healthcare Company Details Table 111. MarksMan Healthcare Business Overview Table 112. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Table 113. MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 114. MarksMan Healthcare Recent Development Table 115. Medpace Holdings Company Details Table 116. Medpace Holdings Business Overview Table 117. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Table 118. Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 119. Medpace Holdings Recent Development Table 120. Novartis Company Details Table 121. Novartis Business Overview Table 122. Novartis Pharmacovigilance (PV) Outsourcing Product Table 123. Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 124. Novartis Recent Development Table 125. Oracle Corporation Company Details Table 126. Oracle Corporation Business Overview Table 127. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Table 128. Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 129. Oracle Corporation Recent Development Table 130. Parexel Company Details Table 131. Parexel Business Overview Table 132. Parexel Pharmacovigilance (PV) Outsourcing Product Table 133. Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 134. Parexel Recent Development Table 135. PharmInvent Company Details Table 136. PharmInvent Business Overview Table 137. PharmInvent Pharmacovigilance (PV) Outsourcing Product Table 138. PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 139. PharmInvent Recent Development Table 140. PrimeVigilance Company Details Table 141. PrimeVigilance Business Overview Table 142. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Table 143. PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 144. PrimeVigilance Recent Development Table 145. Pure Drug Safety Company Details Table 146. Pure Drug Safety Business Overview Table 147. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Table 148. Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 149. Pure Drug Safety Recent Development Table 150. Sciformix Company Details Table 151. Sciformix Business Overview Table 152. Sciformix Pharmacovigilance (PV) Outsourcing Product Table 153. Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 154. Sciformix Recent Development Table 155. SIRO Clinpharm Company Details Table 156. SIRO Clinpharm Business Overview Table 157. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Table 158. SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 159. SIRO Clinpharm Recent Development Table 160. Symogen Company Details Table 161. Symogen Business Overview Table 162. Symogen Pharmacovigilance (PV) Outsourcing Product Table 163. Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2016-2021) & (US$ Million) Table 164. Symogen Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2020 VS 2027 Figure 2. Contract Research Organizations (CROs) Features Figure 3. Business Process Outsourcing (BPOs) Features Figure 4. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2020 VS 2027 Figure 5. Premarketing Clinical Trial Case Studies Figure 6. Post-marketing Clinical Practice Case Studies Figure 7. Other Case Studies Figure 8. Pharmacovigilance (PV) Outsourcing Report Years Considered Figure 9. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions: 2020 VS 2027 Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions (2022-2027) Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2020 Figure 14. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2020 Figure 16. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2016-2021) Figure 17. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2022-2027) Figure 18. North America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2016-2027) Figure 20. North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2016-2027) Figure 21. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2016-2027) Figure 22. United States Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2016-2027) Figure 26. Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2016-2027) Figure 27. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2016-2027) Figure 28. Germany Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Type (2016-2027) Figure 36. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Application (2016-2027) Figure 37. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Region (2016-2027) Figure 38. China Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Type (2016-2027) Figure 46. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Application (2016-2027) Figure 47. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2016-2027) Figure 48. Mexico Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Type (2016-2027) Figure 52. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Application (2016-2027) Figure 53. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2016-2027) Figure 54. Turkey Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 58. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 59. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 60. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 61. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 62. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 63. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 64. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 65. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 66. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 67. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 68. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 69. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 70. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 71. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 72. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 73. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 74. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 75. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 76. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 77. Symogen Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed
Accenture C3i Solutions Clintec Covance Deloitte Touche Tohmatsu Limited ELC Group Ergomed iGATE Corporation iMED Global Corporation IQVIA MarksMan Healthcare Medpace Holdings Novartis Oracle Corporation Parexel PharmInvent PrimeVigilance Pure Drug Safety Sciformix SIRO Clinpharm Symogen
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients